Hepion Pharmaceuticals Inc (HEPA)

NASDAQ
0.627
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.580/0.749
  • Day's Range:
    0.620 - 0.670

HEPA Overview

Prev. Close
0.651
Day's Range
0.62-0.67
Revenue
-
Open
0.65
52 wk Range
1.45-4.8
EPS
-1.68
Volume
0
Market Cap
47.8M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,107,589
P/E Ratio
-
Beta
1.16
1-Year Change
-84.4%
Shares Outstanding
76,225,245
Next Earnings Date
Oct 13, 2021
What is your sentiment on Hepion Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Hepion Pharmaceuticals Inc News

Hepion Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyNeutralStrong SellStrong Sell
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Sell

Hepion Pharmaceuticals Inc Company Profile

Hepion Pharmaceuticals Inc Company Profile

Employees
13

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.

Read More
  • Another offering up for vote, bad news
    0
    • Hepion was supposed to release treatment results in February and they never did. I suggest to newcomers...don't invest here. They lost credibility by missing deadlines. Moreover, investors bought at 2.00 and they are losing. Just wait for news to come in its website then you are welcome to come. Daytraders are likely winning because the oscillations here are so rewarding if you focus on profiting from the continous downtrend, don't wait for miracles in the long term until you have solid news. Cheers
      0
      • Be ready to buy at 1 USD :D....enjoy the ride
        7
        • Poor private company that bought shares at 2.00. They must be regreting. Now I buy at a lower price :). 1.7 is quite delicious. even if it drops to 1 due to the global crisis...is an amazing value for the long run...
          7
          • This comment didn't age well..
            0
        • I like the stock!
          0
          • Why -20% in Pre Market?
            0
            • Buying oppurtinity now, after the offering
              0
              • Wow... Big Red... Cinnamon.
                0
                • Anyone around?
                  0
                  • Nice volume, though.
                    0
                    • As mentioned nash results were given end of December and the company soared..but they are just preliminary results. second jump likely end of January or beginning of February. congrats
                      1
                      • if you miss it you are not late. hepion grows due to covid treatment but the major jump will be nash in January..
                        1
                        • unluckily don't buy this yet.. wait for 1.2 at least.
                          0
                          • good buy. due to new shares given minimal is 1.5 now.
                            0
                          • stats con chris what is the forecast?
                            0
                          • at this level I suggest to trade with the oscillations. between 1.5-1.6 is solid buy. above those numbers... enjoy the oscillations. by january nash treatment results must be available (if not end of December)......for now it will oscillate between 1.5-2.0
                            0
                        • hepa did a good job. thanks. I will come back after earnings. now nothing solid to show. big party in november
                          0
                          • well game over for now. sell 75% and wait for a miracle with a 25%.
                            0
                            • lol it reached 6 and collapsed but still from +70% to +10% Is good enough
                              0
                              • this level at 4 reminds me of the level at 2... makes you feel weak because of the oscillation AND with the need to sell...butttt.. dont sell hold. Is what happened at 2 AND now Is +100% so be positive that this goes to 6
                                3
                                • normal trend... has to go down to get UP again.
                                  0
                                  • adding More. lovely company until 6
                                    0
                                    • buy the dip. this will reach 6
                                      0
                                      • based on what?
                                        0
                                    • I raise my sell at 6 now... likely will sell a small portion between 3 - 4. this company will continue to grow insanely
                                      0
                                      • I'm waiting 3 here but takes forever lol....likely goes to 2.6 then falls back to 2.3 then jumps back to 2.8 and so on ...
                                        0
                                        • eventually...... dont sell even if it drops back. Will jump overall
                                          0
                                          • this company will Explode to 3usd at least .. im adding more and More below 1.6
                                            0
                                            • now Is ok to buy :)
                                              0
                                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.